Foresight Diagnostics to Present Clinical Data at 2021 American Society of Clinical Oncology Annual Meeting

June 3, 2021

  • News

The company will present clinical data of industry-leading Minimal Residual Disease (MRD) technology in lymphoma and lung cancer.